image dons

je fais un don

Fil infos du Groupe ACTION

INFORMATIONS COVID
+

01/02/2008

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervent...
+

07/09/2007

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention....
+

24/01/2007

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up.

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on in...
+

05/09/2006

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial.

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute co...
+

15/04/2003

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated hepa...
+

21/06/2001

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction....